ACUPHARMA ApS: Financial statements 2017
CVR: 10072956
Source: annual report 2017, Danish Business Authority
01/10/2016 – 30/09/2017
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 1,513,402 and a net result of DKK 80,359 compared with DKK 105 the year before. That is an increase of 36.5% compared with the year before. Equity in the 2017 report amounted to DKK 148,750. The solvency ratio was 5.6%.
- Gross Profit
- DKK 1,513,402
- Profit/Loss
- DKK 80,359
- Equity
- DKK 148,750
- Total Assets
- DKK 2,642,948
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 1.5 mio. | 80 t. | 149 t. | - |
| 2016 | - | 1.1 mio. | 105 | 68 t. | - |
| 2015 | - | 322 t. | -360 t. | 68 t. | - |
| 2014 | - | 1.4 mio. | 551 t. | 773 t. | - |
| 2013 | - | 574 t. | -39 t. | 222 t. | - |
Keep an eye on ACUPHARMA ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
ACUPHARMA ApS has published its annual report for 2016. Gross profit came to DKK 1,108,681, and the net result was DKK 105.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.